MAXEON SOLAR TECHNOLOGIE (MAXN)

SGXZ25336314 - Common Stock

2.36  +0.12 (+5.36%)

After market: 2.39 +0.03 (+1.27%)

Fundamental Rating

1

Overall MAXN gets a fundamental rating of 1 out of 10. We evaluated MAXN against 107 industry peers in the Semiconductors & Semiconductor Equipment industry. MAXN has a bad profitability rating. Also its financial health evaluation is rather negative. MAXN is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

MAXN had negative earnings in the past year.
MAXN had a negative operating cash flow in the past year.
In the past 5 years MAXN always reported negative net income.
MAXN had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -12.70%, MAXN is doing worse than 74.53% of the companies in the same industry.
MAXN has a Return On Equity of -97.24%. This is amonst the worse of the industry: MAXN underperforms 83.96% of its industry peers.
Industry RankSector Rank
ROA -12.7%
ROE -97.24%
ROIC N/A
ROA(3y)-19.95%
ROA(5y)-28.1%
ROE(3y)-245.48%
ROE(5y)-185.21%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 10.89%, MAXN is not doing good in the industry: 94.34% of the companies in the same industry are doing better.
MAXN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

MAXN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MAXN has more shares outstanding
Compared to 1 year ago, MAXN has a worse debt to assets ratio.

2.2 Solvency

MAXN has an Altman-Z score of 0.54. This is a bad value and indicates that MAXN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.54, MAXN is doing worse than 73.58% of the companies in the same industry.
MAXN has a Debt/Equity ratio of 2.41. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.41, MAXN is not doing good in the industry: 89.62% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF N/A
Altman-Z 0.54
ROIC/WACCN/A
WACC7.13%

2.3 Liquidity

A Current Ratio of 1.62 indicates that MAXN should not have too much problems paying its short term obligations.
MAXN has a worse Current ratio (1.62) than 79.25% of its industry peers.
A Quick Ratio of 0.88 indicates that MAXN may have some problems paying its short term obligations.
The Quick ratio of MAXN (0.88) is worse than 87.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 0.88

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.31% over the past year.
MAXN shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.11%.
MAXN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.00% yearly.
EPS 1Y (TTM)44.31%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-102.75%
Revenue 1Y (TTM)27.11%
Revenue growth 3Y-4%
Revenue growth 5YN/A
Revenue growth Q2Q-17.35%

3.2 Future

Based on estimates for the next years, MAXN will show a very strong growth in Earnings Per Share. The EPS will grow by 20.02% on average per year.
Based on estimates for the next years, MAXN will show a small growth in Revenue. The Revenue will grow by 6.86% on average per year.
EPS Next Y55.01%
EPS Next 2Y24.22%
EPS Next 3Y20.02%
EPS Next 5YN/A
Revenue Next Year7.65%
Revenue Next 2Y0.74%
Revenue Next 3Y6.06%
Revenue Next 5Y6.86%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MAXN. In the last year negative earnings were reported.
Also next year MAXN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MAXN indicates a rather cheap valuation: MAXN is cheaper than 93.40% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.95

4.3 Compensation for Growth

MAXN's earnings are expected to grow with 20.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.22%
EPS Next 3Y20.02%

0

5. Dividend

5.1 Amount

MAXN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MAXEON SOLAR TECHNOLOGIE

NASDAQ:MAXN (5/3/2024, 7:04:51 PM)

After market: 2.39 +0.03 (+1.27%)

2.36

+0.12 (+5.36%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap124.56M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.7%
ROE -97.24%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 10.89%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.62
Quick Ratio 0.88
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)44.31%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y55.01%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)27.11%
Revenue growth 3Y-4%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y